| Literature DB >> 33832781 |
Artavazd Arumov1, Asaad Trabolsi2, Jonathan H Schatz3.
Abstract
Chemotherapy remains the most widely used cancer treatment modality. Nanotechnology provides exciting opportunities to improve these drugs, transforming decades-old generic treatments into precise new medicines. We illustrate the potential of recent advances in nanotechnology-enhanced therapy focusing on diffuse large B-cell lymphoma (DLBCL); the most common hematologic malignancy.Entities:
Keywords: cancer; drug delivery; lymphoma; nanotechnology; precision medicine; therapeutics
Mesh：
Year: 2021 PMID： 33832781 DOI： 10.1016/j.tibtech.2021.03.004
Source DB: PubMed Journal: Trends Biotechnol ISSN： 0167-7799 Impact factor: 19.536